Minocycline-induced DRESS: Evidence for accumulation of the culprit drug

被引:38
作者
Maubec, Eve [1 ,3 ]
Wolkenstein, Pierre [1 ]
Loriot, Marie-Anne [4 ,5 ]
Wechsler, Janine [2 ]
Mulot, Claire [5 ]
Beaune, Philippe [4 ,5 ]
Revuz, Jean [1 ]
Roujeau, Jean-Claude [1 ]
机构
[1] Hop Henri Mondor, AP HP, Dept Dermatol, Serv Dermatol, FR-94010 Creteil, France
[2] Hop Henri Mondor, AP HP, Dept Pathol, FR-94010 Creteil, France
[3] Hop Bichat Claude Bernard, Dept Dermatol, F-75877 Paris, France
[4] Hop Europeen Georges Pompidou, AP HP, Dept Biochem, Paris, France
[5] Univ Paris 05, Fac Med, INSERM, UMRS 490, Paris, France
关键词
minocycline; drug rash with eosinophilia and systemic symptoms (DRESS); African-American patients; melanin; glutathione S-transferase;
D O I
10.1159/000112926
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 [皮肤病与性病学];
摘要
Background: Minocycline-induced drug rash with eosinophilia and systemic symptoms ( DRESS) may have a prolonged course, especially in African and African-American patients. Objectives: To determine if a prolonged course of minocycline-induced DRESS was associated with an accumulation of the culprit drug. Patients and Methods: We determined plasma and skin levels of minocycline in patients with minocycline-induced DRESS. We investigated the genetic polymorphisms of enzymes potentially involved in the detoxification of the drug, glutathione S-transferases and UDP-glucuronosyltransferases. Results and Conclusions: We demonstrated the persistence of minocycline in the plasma and/or in the skin of 7 out of 9 patients with skin photo-types V-VI. As pigmented skin contains more melanin, this could promote the formation of a melanin-minocycline complex, which could explain the severe and prolonged DRESS which may occur in this subgroup of patients. Copyright (c) 2008 S. Karger AG, Basel.
引用
收藏
页码:200 / 204
页数:5
相关论文
共 25 条
[1]
Ando Y, 2000, CANCER RES, V60, P6921
[2]
MINOCYCLINE-RELATED CUTANEOUS HYPERPIGMENTATION AS DEMONSTRATED BY LIGHT-MICROSCOPY, ELECTRON-MICROSCOPY AND X-RAY-ENERGY SPECTROSCOPY [J].
ARGENYI, ZB ;
FINELLI, L ;
BERGFELD, WF ;
TUTHILL, RJ ;
MCMAHON, JT ;
RATZ, JL ;
PETROFF, N .
JOURNAL OF CUTANEOUS PATHOLOGY, 1987, 14 (03) :176-180
[3]
Beneton N, 1997, LANCET, V349, P1252, DOI 10.1016/S0140-6736(05)62446-4
[4]
Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS) [J].
Bocquet, H ;
Bagot, M ;
Roujeau, JC .
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 1996, 15 (04) :250-257
[5]
Simultaneous characterization of glutathione S-transfersase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks [J].
Chen, CL ;
Liu, Q ;
Relling, MV .
PHARMACOGENETICS, 1996, 6 (02) :187-191
[6]
Chosidow O, 1997, ANN DERMATOL VENER, V124, P726
[7]
Minocycline hypersensitivity syndrome with hypotension mimicking septic shock [J].
Colvin, JH ;
Sheth, AP .
PEDIATRIC DERMATOLOGY, 2001, 18 (04) :295-298
[8]
Genetic polymorphism of cytochrome P450 1A1 (CYP1A1) and glutathione transferases (M1, T1 and P1) among Africans [J].
Dandara, C ;
Sayi, J ;
Masimirembwa, CM ;
Magimba, A ;
Kaaya, S ;
De Sommers, K ;
Snyman, JR ;
Hasler, JA .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2002, 40 (09) :952-957
[9]
SKIN PIGMENTATION DUE TO MINOCYCLINE TREATMENT OF FACIAL DERMATOSES [J].
DWYER, CM ;
CUDDIHY, AM ;
KERR, REI ;
CHAPMAN, RS ;
ALLAM, BF .
BRITISH JOURNAL OF DERMATOLOGY, 1993, 129 (02) :158-162
[10]
Minocycline-induced pigmentation - Incidence, prevention and management [J].
Eisen, D ;
Hakim, MD .
DRUG SAFETY, 1998, 18 (06) :431-440